Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Vaccination in HIV-Exposed Infants
NCT00331474Phase 2Unknown
- Sponsor
- Stellenbosch University
- Start
- May 2006
- Primary completion
- Dec 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bcg vaccine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Stellenbosch University. Primary endpoint: BCG-induced cellular immune responses at 1 year. Status: unknown.
02
Drugs
bcg vaccine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00331474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00331474.